BSX Boston Scientific

  • Official Name: BOSTON SCIENTIFIC CORPORATION
  • Headquarters: 300 Boston Scientific Way, MARLBOROUGH, MA, 01752-1234 US
  • CEO: Michael F. Mahoney
  • Website: bostonscientific.com
  • Key Investor: BLACKROCK, INC | 9.58%
  • Dedicated Investor: BOLLARD GROUP LLC | 54.28%

Match Results

Date League Week Opponent Result Score
2025-07-16
PSL
1 Won by 0.219 0.169 - (0.050)
2025-07-23
PSL
2 Lost by 0.660 3.983 - 4.643
2025-07-29 2R Lost by 0.105 1.003 - 1.108
2025-07-30
PSL
3 Lost by 1.300 (0.105) - 1.195
2025-08-06
PSL
4 Lost by 5.150 (4.032) - 1.118
2025-08-07 1R Won by 0.265 0.078 - (0.187)
2025-08-13
PSL
5 Lost by 0.628 (0.513) - 0.115
2025-08-20
PSL
6 Won by 1.320 3.214 - 1.894
2025-08-21 2R Lost by 2.287 (1.006) - 1.281
2025-08-27
PSL
7 Lost by 2.799 (0.168) - 2.631
2025-09-03
PSL
8 Won by 1.575 TOTW 1.713 - 0.138
2025-09-10
PSL
9 Lost by 2.594 (2.114) - 0.480
2025-09-17
PSL
10 Lost by 5.920 (5.060) - 0.860
2025-09-17
LgC
1R Lost by 2.180 (0.437) - 1.743
2025-09-24
PSL
11 Won by 1.291 (0.387) - (1.678)
2025-10-01
PSL
12 Won by 3.447 (1.976) - (5.423)
2025-10-08
PSL
13 Won by 4.077 0.862 - (3.215)
2025-10-15
PSL
14 Won by 2.050 0.924 - (1.126)
2025-10-22
PSL
15 Won by 6.882 6.754 - (0.128)

Latest News

Q3 Earnings Roundup: Boston Scientific (NYSE:BSX) And The Rest Of The Medical Devices & Supplies - Diversified Segment
Yahoo - 2025-11-24

Q3 Earnings Roundup: Boston Scientific (NYSE:BSX) And The Rest Of The Medical Devices & Supplies - Diversified Segment 🔗

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are lo...

GE HealthCare to Acquire Intelerad for $2.3B to Boost Cloud Imaging
Yahoo - 2025-11-24

GE HealthCare to Acquire Intelerad for $2.3B to Boost Cloud Imaging 🔗

GEHC's $2.3B Intelerad deal aims to accelerate cloud imaging growth, expand outpatient reach and boost its shift toward high-margin SaaS revenue.

Defibrillator Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts
Yahoo - 2025-11-24

Defibrillator Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts 🔗

The global defibrillator market is forecasted to expand significantly, increasing from US$ 13.74 billion in 2024 to US$ 25.80 billion by 2033, with a ...

Okami raises $45M to commercialize vascular embolization devices
Yahoo - 2025-11-24

Okami raises $45M to commercialize vascular embolization devices 🔗

The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.

BSX vs. EW: Which Heart Device Stock Is the Smarter Investment Now?
Yahoo - 2025-11-24

BSX vs. EW: Which Heart Device Stock Is the Smarter Investment Now? 🔗

Boston Scientific's EP breadth, WATCHMAN momentum and acquisitions give it an edge over Edwards in cardiovascular devices.

Should You Hold Quest Diagnostics Stock in Your Portfolio for Now?
Yahoo - 2025-11-24

Should You Hold Quest Diagnostics Stock in Your Portfolio for Now? 🔗

DGX pushes growth through acquisitions and advanced diagnostics even as rising debt and tough competition pressure its outlook.

Boston Scientific (BSX): Evaluating Valuation as Investors Weigh Growth and Competitive Position
Yahoo - 2025-11-22

Boston Scientific (BSX): Evaluating Valuation as Investors Weigh Growth and Competitive Position 🔗

Boston Scientific (BSX) stock has been on the move recently, catching the attention of investors interested in healthcare innovation. With earnings mo...

Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know
Yahoo - 2025-11-21

Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know 🔗

Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)...

Boston Scientific (BSX) Down 5.7% Since Last Earnings Report: Can It Rebound?
Yahoo - 2025-11-21

Boston Scientific (BSX) Down 5.7% Since Last Earnings Report: Can It Rebound? 🔗

Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Veeva Systems Stock Down Despite Q3 Earnings & Revenues Top Estimates
Yahoo - 2025-11-21

Veeva Systems Stock Down Despite Q3 Earnings & Revenues Top Estimates 🔗

VEEV posts a Q3 earnings beat with stronger subscription growth and higher full-year guidance, highlighting continued momentum.

Reasons to Hold AngioDynamics Stock in Your Portfolio for Now
Yahoo - 2025-11-21

Reasons to Hold AngioDynamics Stock in Your Portfolio for Now 🔗

ANGO benefits from NanoKnife, clinical milestones and a balanced portfolio despite tariff headwinds.

Are Medical Stocks Lagging  Cencora, Inc. (COR) This Year?
Yahoo - 2025-11-21

Are Medical Stocks Lagging Cencora, Inc. (COR) This Year? 🔗

Here is how Cencora (COR) and Boston Scientific (BSX) have performed compared to their sector so far this year.

LH Shares Gain Following Publication of New Plasma Detect MRD Data
Yahoo - 2025-11-21

LH Shares Gain Following Publication of New Plasma Detect MRD Data 🔗

Labcorp shares edge higher as new studies spotlight Plasma Detect's role in tracking MRD and improving post-surgery cancer detection.

Show more
SeekingAlpha - 2025-09-30

2025 Investor Day Call 🔗